U.S. Markets open in 3 hrs 35 mins

Pharmaxis Ltd (PXS.AX)

ASX - ASX Delayed Price. Currency in AUD
Add to watchlist
0.265-0.005 (-1.852%)
At close: 4:10PM AEST
Full screen
Previous Close0.270
Open0.275
Bid0.265 x 13670200
Ask0.275 x 3467100
Day's Range0.260 - 0.275
52 Week Range0.227 - 0.315
Volume477,377
Avg. Volume186,275
Market Cap84.62M
BetaN/A
PE Ratio (TTM)-5.20
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Pharmaxis Ltd. :PXS-AU: Earnings Analysis: For the six months ended June 30, 2017 : August 14, 2017
    Capital Cube6 days ago

    Pharmaxis Ltd. :PXS-AU: Earnings Analysis: For the six months ended June 30, 2017 : August 14, 2017

    Categories: Yahoo FinanceGet free summary analysis Pharmaxis Ltd. reports financial results for the half-year ended June 30, 2017. Highlights Summary numbers: Revenues of AUD 7.45 million, Net Earnings of AUD -7.31 million. Gross margins narrowed from 26.13% to -3.80% compared to the same period last year, operating (EBITDA) margins now -129.03% from -64.92%. Earnings rose compared to ... Read more (Read more...)

  • Pharmaxis Ltd. :PXS-AU: Earnings Analysis: 2017 By the Numbers : August 14, 2017
    Capital Cube6 days ago

    Pharmaxis Ltd. :PXS-AU: Earnings Analysis: 2017 By the Numbers : August 14, 2017

    Categories: Yahoo FinanceGet free summary analysis Pharmaxis Ltd. reports financial results for the year ended June 30, 2017. Highlights Gross margins narrowed from -8.02% to -12.15% compared to the same period last year, operating (EBITDA) margins now -139.63% from -133.75%. Change in operating cash flow of -27.30% compared to same period last year is about the same ... Read more (Read more...)

  • Pharmaxis Ltd. :PXS-AU: Earnings Analysis: Q2, 2016 By the Numbers
    Capital Cubelast year

    Pharmaxis Ltd. :PXS-AU: Earnings Analysis: Q2, 2016 By the Numbers

    Click here to see latest analysisPharmaxis Ltd. reports financial results for the quarter ended December 31, 2015.HighlightsGross margins narrowed from 4.57% to -126.60% compared to the same period last year, operating (EBITDA) margins now -465.67% from -465.84%.Earnings growth from operating margin improvements as well as one-time items.The table below shows the preliminary results and recent […] (Read more...) The post Pharmaxis Ltd. :PXS-AU: Earnings Analysis: Q2, 2016 By the Numbers appeared first on CapitalCube.